We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UWMC icon
276
UWM Holdings
UWMC
$2.36B
$40.5K ﹤0.01%
+11,663
New +$53.7K
GERN icon
277
Geron
GERN
$977M
$36.2K ﹤0.01%
25,657
+10,229
+66% +$15.5K
ALIT icon
278
Alight
ALIT
$380M
$10.4K ﹤0.01%
+933
New +$22.2K
ABG icon
279
Asbury Automotive
ABG
$3.83B
-1,833
Closed -$433K
BLDR icon
280
Builders FirstSource
BLDR
$7.21B
-2,744
Closed -$283K
CDW icon
281
CDW
CDW
$18.8B
-7,463
Closed -$1.02M
CFLT
282
DELISTED
Confluent
CFLT
-25,468
Closed -$770K
CYBR
283
DELISTED
CyberArk
CYBR
-50,142
Closed -$22.4M
DOCS icon
284
Doximity
DOCS
$4.71B
-16,884
Closed -$749K
DYN icon
285
Dyne Therapeutics
DYN
$4.72B
-680,305
Closed -$13.3M
ENGN icon
286
enGene Therapeutics
ENGN
$123M
-950,000
Closed -$8.58M
EXAS
287
DELISTED
Exact Sciences
EXAS
-254,921
Closed -$25.9M
FHN icon
288
First Horizon
FHN
$11.6B
-9,023
Closed -$216K
GTLB icon
289
GitLab
GTLB
$7.59B
-12,782
Closed -$480K
IDYA icon
290
IDEAYA Biosciences
IDYA
$3.94B
-284,069
Closed -$9.82M
INSP icon
291
Inspire Medical Systems
INSP
$1.79B
-440,205
Closed -$40.6M
IVA
292
Inventiva
IVA
$1.11B
-250,000
Closed -$1.16M
KMX icon
293
CarMax
KMX
$8.89B
-6,776
Closed -$266K
KVUE icon
294
Kenvue
KVUE
$37.1B
-13,741
Closed -$238K
KVYO icon
295
Klaviyo
KVYO
$5.69B
-15,555
Closed -$506K
MNDY icon
296
monday.com
MNDY
$4.26B
-91,472
Closed -$13.5M
OLMA icon
297
Olema Pharmaceuticals
OLMA
$921M
-569,000
Closed -$14.2M
PI icon
298
Impinj
PI
$5.24B
-2,189
Closed -$380K
POOL icon
299
Pool Corp
POOL
$6.77B
-2,190
Closed -$506K
QURE icon
300
uniQure
QURE
$3.38B
-498,212
Closed -$11.9M

Similar funds

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.